China has successfully transitioned from a producer of simple active pharmaceutical ingredients (APIs) to a global leader in high-quality finished dosage forms. The China Generic Pharmaceuticals Market is driven by the government’s "Volume-Based Procurement" (VBP) policy, which aims to drastically reduce the cost of essential medicines for its massive population. This policy has forced...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek